Background: Using two case reports of adult women with moyamoya disease presenting with intracranial hemorrhage from ruptured aneurysms on moyamoya collateral vessels, we aim to demonstrate the potential for effective endovascular treatment navigated by CT angiography, digital subtraction angiography, and flat panel CT. Case 1 Presentation: A 45-year-old female patient with sudden onset of headache, followed by somnolency. CT scan showed a four-ventricle hematocephalus caused by a 27 × 31 × 17 mm hematoma located in the left basal ganglia. Angiography revealed a 3 mm aneurysm on hypertrophic lenticulostriate artery bridging the M1 occlusion. Selective catheterization and distal embolisation with acrylic glue was done. Case 2 Presentation: A 47-year-old woman was admitted for a sudden onset of severe headache, CT scan showed four-ventricle hematocephalus. A 4 mm aneurysm on the collateral vessel-anterior chorioidal artery bridging the closure of the terminal segment of the internal carotid artery was diagnosed as the source of bleeding. Selective catheterization and distal embolisation with acrylic glue was done. Conclusions: Selective embolisation of ruptured aneurysms on moya moya collaterals is a simple, effective, and safe procedure when relevant microcatheters are used with imaging software navigation such as 3D DSA, 3D road map and flat-panel CT.

Department of Neurology University Hospital Faculty of Medicine Charles University 50005 Hradec Kralove Czech Republic

Department of Neurosurgery University Hospital Faculty of Medicine Charles University 50005 Hradec Kralove Czech Republic

Department of Radiology University Hospital 50005 Hradec Kralove Czech Republic

Faculty of Medicine in Hradec Kralove Charles University 50003 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Suzuki J., Takaku A. Cerebrovascular moyamoya disease: Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 1969;20:288–299. doi: 10.1001/archneur.1969.00480090076012. PubMed DOI

Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) Neurol. Med.-Chir. 2012;52:245–266. doi: 10.2176/nmc.52.245. PubMed DOI

Demartini Z., Jr., Teixeira B.C., Koppe G.L., Gatto L.A.M., Roman A., Munhoz R.P. Moyamoya disease and syndrome: A review. Radiol. Bras. 2022;55:31–37. doi: 10.1590/0100-3984.2021.0010. PubMed DOI PMC

Arboix A., Besses C. Cerebrovascular disease as the initial clinical presentation of haematological disorders. Eur. Neurol. 1997;37:207–211. doi: 10.1159/000117444. PubMed DOI

Smith E.R., Scott R.M. Spontaneous occlusion of the circle of Willis in children: Pediatric moyamoya summary with proposed evidence-based practice guidelines: A review. J. Neurosurg. Pediatr. 2012;9:353–360. doi: 10.3171/2011.12.PEDS1172. PubMed DOI

Czabanka M., Peña-Tapia P., Schubert G., Heppner F., Martus P., Horn P., Schmiedek P., Vajkoczy P. Proposal for a new grading of moyamoya disease in adult patients. Cerebrovasc. Dis. 2011;32:41–50. doi: 10.1159/000326077. PubMed DOI

Wiedmann M.K.H., Davidoff C., Lo Presti A., Ni W., Rhim J.K., Simons M., Stoodley M.A. Treatment of ruptured aneurysms of the choroidal collateral system in moyamoya disease: A systematic review and data analysis. J. Neurosurg. 2021;136:637–646. doi: 10.3171/2021.1.JNS203936. PubMed DOI

Fujimura M., Tominaga T. Hemorrhagic moyamoya isease: A recent update. J. Korean Neurosurg. Soc. 2019;62:136–143. doi: 10.3340/jkns.2018.0101. PubMed DOI PMC

Kim S., Jang C.K., Park E.K., Shim K.W., Kim D.S., Chung J., Kim Y.B., Lee J.W., Park K.Y. Clinical features and outcomes of intracranial aneurysm associated with moyamoya disease. J. Clin. Neurol. 2020;16:624–632. doi: 10.3988/jcn.2020.16.4.624. PubMed DOI PMC

Zhao X., Wang X., Wang M., Meng Q., Wang C. Treatment strategies of ruptured intracranial aneurysms associated with moyamoya disease. Br. J. Neurosurg. 2021;35:209–215. doi: 10.1080/02688697.2020.1781058. PubMed DOI

Yang H., Hu Z., Gao X., Su J., Jiang H., Yang S., Zhang Q., Ni W., Gu Y. Safety and efficacy of remote ischemic conditioning in adult moyamoya disease patients undergoing revascularization surgery: A pilot study. Front. Neurol. 2023;14:1200534. doi: 10.3389/fneur.2023.1200534. PubMed DOI PMC

Hou K., Li G., Luan T., Xu K., Yu J. The prospects and pitfalls in the endovascular treatment of moyamoya disease–associated intracranial aneurysms. Neurosurg. Rev. 2021;44:261–271. doi: 10.1007/s10143-020-01261-y. PubMed DOI

Choulakian A., Drazin D., Alexander M.J. NBCA embolization of a ruptured intraventricular distal anterior choroidal artery aneurysm in a patient with moyamoya disease. J. NeuroInterv. Surg. 2010;2:368–370. doi: 10.1136/jnis.2010.002253. PubMed DOI

Liu P., Lv X., Li Y., Lv M. Onyx embolization of a ruptured rotundum foramen artery aneurysm in a patient with moyamoya disease: A case report. World Neurosurg. 2015;84:e1171–e1173. doi: 10.1016/j.wneu.2015.06.039. PubMed DOI

Zhuang Z., Zhu Q., Liu X.-Z., Ling H.-P., Na S.-J., Liu T., Zhang Y.-H., Hang C.-H., Liu K.-D., Zhang Q.-R. Efficacy of liquid embolic agent treatment in hemorrhagic peripheral intracranial aneurysms: A single-center experience. Brain Sci. 2022;12:1264. doi: 10.3390/brainsci12091264. PubMed DOI PMC

Larson A.S., Rinaldo L., Brinjikji W., Lanzino G. Location-based treatment of intracranial aneurysms in moyamoya disease: A systematic review and descriptive analysis. Neurosurg. Rev. 2021;44:1127–1139. doi: 10.1007/s10143-020-01307-1. PubMed DOI

Yamada H., Saga I., Kojima A., Horiguchi T. Short-Term Spontaneous Resolution of Ruptured Peripheral Aneurysm in Moyamoya Disease. World Neurosurg. 2019;126:247–251. doi: 10.1016/j.wneu.2019.02.193. PubMed DOI

Ni W., Jiang H., Xu B., Lei Y., Yang H., Su J., Gu Y., Mao Y. Treatment of aneurysms in patients with moya moya disease: A 10 year single center experience. J. Neurosurg. 2018;128:1813–1822. doi: 10.3171/2017.3.JNS162290. PubMed DOI

Takahashi J.C., Funaki T., Houkin K., Inoue T., Ogasawara K., Nakagawara J., Kuroda S., Yamada K., Miyamoto S. Significance of the hemorrhagic site for recurrent bleeding: Prespecified analysis in the Japan adult moyamoya trial. Stroke. 2016;47:37–43. doi: 10.1161/STROKEAHA.115.010819. PubMed DOI

Sutton C.X.Y., Carrazana E., Mitchell C., Viereck J., Liow K.K., Ghaffari-Rafi A. Identification of associations and distinguishing moyamoya disease from ischemic strokes of other etiologies: A retrospective case-control study. Ann. Med. Surg. 2022;78:103771. doi: 10.1016/j.amsu.2022.103771. PubMed DOI PMC